Why is Venmax Drugs falling/rising?

As of 16-September, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 24.77, which represents a decrease of Rs 1.28 or 4.91%. The stock has underperformed its sector by 5.19% today and has been on a consecutive downward trend for the last two days, resulting in a total loss of 9.47% during this period. The stock opened with a significant loss of 4.03% and reached an intraday low of Rs 24.75. Additionally, the stock's delivery volume has drastically fallen by 89.56% compared to the 5-day average, indicating a decrease in investor participation. While the stock is trading above its 200-day moving average, it is below its 5-day, 20-day, 50-day, and 100-day moving averages, suggesting a bearish trend. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Venmax's performance over the past week shows a decline of 1.71%, while the benchmark Sensex has increased by 1.58%. Over the past month, the stock has fallen by 13.12%, contrasting with a 2.21% rise in the Sensex. Year-to-date, however, Venmax has shown a positive return of 37.31%, significantly outperforming the Sensex's 5.43% gain. This indicates that while the stock has had a strong performance in the longer term, recent short-term trends suggest a struggle against both sector performance and broader market movements.